Signaling Pathways - Inward Rectifier Potassium (Kir) Channels - ATP synthase - DOT1L - NO Donors / Precursors
清除全部
-
B3492 Bedaquiline中文名: 贝达喹啉Target: ATP synthaseSummary: 抗结核药物 -
B2198 Nateglinide中文名: 那格列奈Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 胰岛素促分泌剂 -
B2195 Gliclazide中文名: 格列齐特Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 钾通道抑制剂 -
B1581 EPZ004777 HClTarget: DOT1LSummary: DOT1L抑制剂 -
B2193 Mitiglinide Calcium中文名: 米格列奈钙Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 钾通道抑制剂 -
B1296 Glibenclamide中文名: 格列本脲Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 胰岛素生产调节剂 -
A8534 Terfenadine中文名: 特非那定Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) ChannelsSummary: 组胺H1受体拮抗剂 -
A3850 TAK-2427 Citation中文名: 瑞沙托维Target: Toll-like receptors (TLRs)|NO Donors / Precursors|IL ReceptorsSummary: TLR 4信号抑制剂 -
A4170 EPZ004777Target: DOT1LSummary: DOT1L抑制剂 -
A4033 Glimepiride中文名: 格列美脲Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 磺酰脲类化合物